Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial.

Autor: Scanlon E; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Lavery A; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Albraikat M; Precision Medicine Centre of Excellence, The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Stevenson L; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Kennedy C; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Byrne R; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Walker A; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Mullan-Young B; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., McManus DT; Department of Pathology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast., Virdee PS; Centre for Statistics in Medicine, University of Oxford, Oxford., Elhussein L; Centre for Statistics in Medicine, University of Oxford, Oxford., Turbitt J; Medical Genetics, School of Medicine, Medical Sciences, Nutrition and Dentistry, University of Aberdeen, Aberdeen., Collinson D; Medical Genetics, School of Medicine, Medical Sciences, Nutrition and Dentistry, University of Aberdeen, Aberdeen., Miedzybrodzka Z; Medical Genetics, School of Medicine, Medical Sciences, Nutrition and Dentistry, University of Aberdeen, Aberdeen., Van Schaeybroeck S; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., McQuaid S; Precision Medicine Centre of Excellence, The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast; Department of Pathology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast; Northern Ireland Biobank, The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., James JA; Precision Medicine Centre of Excellence, The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast; Department of Pathology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast; Northern Ireland Biobank, The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Craig SG; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Blayney JK; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast., Petty RD; Division of Molecular and Clinical Medicine, Ninewells Hospital and School of Medicine, University of Dundee, Dundee., Harkin DP; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast; Almac Diagnostic Services Ltd, Craigavon., Kennedy RD; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast; Almac Diagnostic Services Ltd, Craigavon., Eatock MM; Northern Ireland Cancer Centre, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast., Middleton MR; Department of Oncology, University of Oxford, Oxford., Thomas A; University of Leicester, Leicester, UK., Turkington RC; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast. Electronic address: r.turkington@qub.ac.uk.

Publikováno v: ESMO open [ESMO Open] 2024 Oct 11; Vol. 9 (11), pp. 103930. Date of Electronic Publication: 2024 Oct 11.

Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy.

Autor: Allen WL; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Dunne PD; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., McDade S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Scanlon E; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Loughrey M; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Coleman H; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., McCann C; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., McLaughlin K; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Nemeth Z; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Syed N; Sidra Medical and Research Center, Qatar., Jithesh P; Sidra Medical and Research Center, Qatar., Arthur K; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Wilson R; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Coyle V; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., McArt D; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Murray GI; NHS Grampian, Aberdeen., Samuel L; NHS Grampian, Aberdeen., Nuciforo P; University Hospital Vall d'Hebron, Barcelona, Spain., Jimenez J; University Hospital Vall d'Hebron, Barcelona, Spain., Argiles G; University Hospital Vall d'Hebron, Barcelona, Spain., Dienstmann R; University Hospital Vall d'Hebron, Barcelona, Spain., Tabernero J; University Hospital Vall d'Hebron, Barcelona, Spain., Messerini L; University of Florence, Italy., Nobili S; University of Florence, Italy., Mini E; University of Florence, Italy., Sheahan K; School of Medicine and Medical Science, University College Dublin., Ryan E; School of Medicine and Medical Science, University College Dublin., Johnston PG; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Van Schaeybroeck S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Lawler M; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK., Longley DB; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2018 Jun 13; Vol. 2018.

Murine RARbeta4 displays reduced transactivation activity, lower affinity for retinoic acid, and no anti-AP1 activity.

Autor: Soprano DR; Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA., Scanlon E, Shukri M, Zhang ZP, Soprano KJ

Publikováno v: Journal of cellular biochemistry [J Cell Biochem] 2000 Apr; Vol. 77 (4), pp. 604-14.

Do cancers invade veins?

Autor: Scanlon E; Departments of Surgery, Evanston Hospital, IL 60201., Murthy S, Groothuis D

Publikováno v: Archives of surgery (Chicago, Ill. : 1960) [Arch Surg] 1992 Apr; Vol. 127 (4), pp. 389-91.

Surgical management of mediastinal tumors.

Autor: DORSEY JM, SCANLON E

Publikováno v: A.M.A. archives of surgery [AMA Arch Surg] 1950 Oct; Vol. 61 (4), pp. 677-83.